Michael J Welch Selected Research

Michael J Welch Research Topics

Disease

48	Neoplasms (Cancer) 01/2016 - 01/2002
18	Breast Neoplasms (Breast Cancer) 11/2012 - 11/2002
15	Hypoxia (Hypoxemia) 05/2010 - 03/2002
9	Prostatic Neoplasms (Prostate Cancer) 10/2012 - 11/2002
7	Carcinoma (Carcinomatosis) 01/2012 - 04/2003
5	Asthma (Bronchial Asthma) 09/2016 - 01/2004
4	Melanoma (Melanoma, Malignant) 05/2009 - 04/2005
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2008 - 04/2003
3	Inflammation (Inflammations) 10/2013 - 01/2012
3	Atherosclerosis 07/2013 - 01/2010
3	Diabetic Cardiomyopathies 08/2008 - 01/2002
3	Cardiomyopathies (Cardiomyopathy) 12/2007 - 01/2002
2	Type 2 Diabetes Mellitus (MODY) 09/2009 - 08/2008
2	Ischemia 01/2009 - 12/2007
2	Necrosis 07/2005 - 11/2002
1	Peanut Hypersensitivity (Peanut Allergy) 11/2018
1	Vascular System Injuries 07/2013
1	Adenocarcinoma 01/2012
1	Carcinogenesis 01/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2012
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 06/2011
1	Glioblastoma (Glioblastoma Multiforme) 02/2011

Drug/Important Bio-Agent (IBA)

11	LigandsIBA 10/2012 - 03/2002
9	Estrogen ReceptorsIBA 11/2012 - 05/2003
8	RadiopharmaceuticalsIBA 11/2012 - 08/2002
7	Glucose (Dextrose)FDA LinkGeneric 05/2010 - 01/2002
7	copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA 08/2008 - 11/2002
6	Progesterone Receptors (Progesterone Receptor)IBA 07/2012 - 07/2006
5	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2016 - 09/2004
5	Peptides (Polypeptides)IBA 02/2011 - 07/2003
4	Hormones (Hormone)IBA 07/2012 - 10/2005
4	Estrogens (Estrogen)FDA Link 07/2012 - 03/2005
4	Biomarkers (Surrogate Marker)IBA 07/2012 - 06/2006
4	CopperIBA 06/2011 - 03/2002
4	Acetates (Acetic Acid Esters)FDA Link 10/2009 - 02/2002
4	alpha-MSHIBA 05/2009 - 04/2005
4	Biological ProductsIBA 04/2009 - 08/2003
4	Androgen Receptors (Androgen Receptor)IBA 03/2007 - 03/2005
4	AndrogensIBA 03/2007 - 11/2002
4	Radioisotopes (Radionuclides)IBA 07/2005 - 08/2003
3	Monoclonal AntibodiesIBA 01/2016 - 08/2003
3	Pharmaceutical PreparationsIBA 10/2013 - 07/2005
3	Progestins (Progestagens)IBA 07/2012 - 07/2006
3	Estradiol (Delestrogen)FDA LinkGeneric 07/2012 - 11/2003
3	PPAR gammaIBA 01/2012 - 10/2006
3	IntegrinsIBA 02/2011 - 09/2004
3	LipidsIBA 10/2009 - 02/2005
3	Oxygen (Dioxygen)IBA 10/2009 - 05/2004
3	Deoxyglucose (2 Deoxy D glucose)IBA 02/2009 - 09/2003
3	PPAR alphaIBA 12/2007 - 01/2002
3	Fatty Acids (Saturated Fatty Acids)IBA 12/2007 - 01/2002
3	RheniumIBA 11/2007 - 11/2003
3	Folic Acid (Vitamin M)FDA LinkGeneric 06/2006 - 10/2003
2	Proteins (Proteins, Gene)FDA Link 11/2018 - 08/2008
2	SteroidsIBA 07/2012 - 01/2012
2	Atrial Natriuretic Factor (ANF)IBA 12/2011 - 01/2010
2	Natriuretic PeptidesIBA 12/2011 - 01/2010
2	Therapeutic UsesIBA 01/2011 - 03/2004
2	Carbon-11IBA 12/2010 - 07/2005
2	GoldIBA 11/2010 - 04/2010
2	Chelating AgentsIBA 05/2009 - 04/2009
2	MetalsIBA 05/2009 - 11/2003
2	Integrin beta3 (GPIIIa)IBA 04/2009 - 09/2004
2	fluoromisonidazoleIBA 08/2008 - 04/2005
2	Fluticasone (Cutivate)FDA LinkGeneric 01/2008 - 01/2004
2	benzamideIBA 07/2007 - 06/2006
2	1,4,7,10-tetraazacyclododecane 1,4,7,10-tetraacetic acid (ReO- acetyl(Cys(3,4,10),Phe(7),Arg(7))alpha- MSH(3- 13))IBA 01/2007 - 04/2005
2	Estrogen Receptor alphaIBA 10/2005 - 05/2003
2	Estrogen Receptor betaIBA 10/2005 - 05/2003
2	Technetium (Technetium 99m)IBA 03/2005 - 11/2003
2	ThiosemicarbazonesIBA 02/2005 - 03/2002
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2002 - 01/2002
1	Albuterol (Salbutamol)FDA LinkGeneric 09/2016
1	patritumabIBA 01/2016
1	Somatostatin Receptors (Somatostatin Receptor)IBA 10/2013
1	Apolipoproteins E (ApoE)IBA 07/2013
1	ApolipoproteinsIBA 07/2013
1	(64)Cu-DOTA-vMIP-IIIBA 07/2013
1	ChemokinesIBA 07/2013
1	Chemokine ReceptorsIBA 07/2013
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2013
1	HaptoglobinsIBA 10/2012
1	Fulvestrant (Faslodex)FDA Link 07/2012
1	Indicators and Reagents (Reagents)IBA 07/2012
1	Progesterone FDA LinkGeneric 03/2012
1	STAT Transcription FactorsIBA 01/2012
1	Phenobarbital (Luminal)FDA Link 01/2012
1	conatumumabIBA 06/2011
1	Trastuzumab (Herceptin)FDA Link 04/2011
1	Docetaxel (Taxotere)FDA Link 01/2011
1	SurvivinIBA 12/2010
1	LY 2181308IBA 12/2010
1	Antisense OligonucleotidesIBA 12/2010

Therapy/Procedure

25	Therapeutics 11/2012 - 01/2002
11	Radiotherapy 02/2011 - 04/2003
4	Drug Therapy (Chemotherapy) 11/2008 - 04/2003
1	Immunotherapy 11/2018
1	Nebulizers and Vaporizers (Inhaler) 09/2016
1	Dry Powder Inhalers 09/2016
1	Precision Medicine 04/2012